Detalles de la búsqueda
1.
Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.
Clin Trials
; 12(3): 246-56, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25691600
2.
Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.
Cancer
; 120(6): 877-84, 2014 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24327389
3.
Update on Enrollment of Older Adults Onto National Cancer Institute National Clinical Trials Network Trials.
J Natl Cancer Inst Monogr
; 2022(60): 111-116, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519819
4.
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials.
J Natl Cancer Inst
; 114(11): 1437-1440, 2022 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047830
5.
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
Clin Cancer Res
; 27(9): 2394-2399, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563632
6.
The National Cancer Institute and Department of Veterans Affairs Interagency Group to Accelerate Trials Enrollment (NAVIGATE): A federal collaboration to improve cancer care.
Semin Oncol
; 46(4-5): 308-313, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711680
7.
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.
J Clin Oncol
; : JCO2018788620, 2018 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30204536
8.
A Randomized Controlled Study Comparing the National Cancer Institute's Original and Revised Consent Form Templates.
IRB
; 39(5): 1-7, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703315
9.
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
JAMA Oncol
; 3(8): 1043-1050, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28208174
10.
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
J Clin Oncol
; 35(33): 3737-3744, 2017 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28968170
11.
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
Int J Radiat Oncol Biol Phys
; 98(2): 409-418, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28463161
12.
Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community.
J Oncol Pract
; 12(1): 63-4, e23-35, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26627979
13.
Strengthening accrual to cancer clinical trials.
Gynecol Oncol
; 116(3): 291-2, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20152512
14.
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
JAMA Oncol
; 1(8): 1051-9, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26270597
15.
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.
J Natl Cancer Inst
; 106(7)2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25006191
16.
Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.
J Oncol Pract
; 10(2): e73-80, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24424313
17.
Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.
J Oncol Pract
; 9(2): e55-61, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23814525
18.
Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials.
J Natl Cancer Inst
; 105(13): 954-9, 2013 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23776198
19.
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
J Oncol Pract
; 9(6): 267-76, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24130252
20.
Clinical trials referral resource. Current clinical trials in the treatment of colorectal cancer.
Oncology (Williston Park)
; 20(8): 830, 832, 837-8 passim, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16922257